Effectiveness of Online Mindfulness Platform in Improving Anxiety, Depression, and Stress in Adult
1 other identifier
interventional
60
1 country
1
Brief Summary
During the COVID-19 pandemic, adults may experience emotional stress and impact. To reduce the risk of cross-infection, this study aims to use online mindfulness training to improve emotional well-being during the pandemic and assess their effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2023
CompletedFirst Submitted
Initial submission to the registry
August 29, 2024
CompletedFirst Posted
Study publicly available on registry
September 26, 2024
CompletedOctober 3, 2024
August 1, 2024
4 months
August 29, 2024
October 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of anxiety
Anxiety levels were assessed using the odd-numbered questions of the Hospital Anxiety and Depression Scale (HADS-14). The full title of HADS-14 is Hospital Anxiety and Depression Scale. This scale consists of 14 items, with 7 items specifically measuring anxiety, known as the Anxiety Subscale (HADS-A). Each item in the Anxiety Subscale is rated on a 4-point Likert scale, ranging from 0 (no symptoms) to 3 (significant symptoms). The total score for the anxiety subscale can range from 0 to 21. Higher scores indicate worse outcomes, specifically reflecting greater levels of anxiety. The scoring is categorized as follows: * 0-7: Normal anxiety levels * 8-10: Borderline abnormal anxiety (suggesting possible anxiety) * 11-21: Abnormal anxiety (indicating clinical levels of anxiety)
Anxiety was assessed before the intervention, and at 4 and 8 weeks after the intervention.
Secondary Outcomes (1)
Assessment of depression
Depression was assessed before the intervention, and at 4 and 8 weeks after the intervention.
Other Outcomes (1)
Assessment of stress
Stress levels were assessed before the intervention, and at 4 and 8 weeks after the intervention.
Study Arms (1)
online mindfulness group
EXPERIMENTALPatients in the experimental group received online mindfulness interventions at least once a week approximately 15-20 minutes each time.
Interventions
Use publicly available online mindfulness training resources. The training content was to guide patients to practice mindfulness techniques, including "where the body is, the mind is" and "relaxation learning".
Eligibility Criteria
You may qualify if:
- Patients over 20 years of age
- Conscious
- Able to communicate in Taiwanese
You may not qualify if:
- Patients currently receiving antidepressant or anti-anxiety medications
- Patients unable to communicate verbally
- Patients who refuse to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Medical University Hospital
Taipei, Xinyi District, 110, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2024
First Posted
September 26, 2024
Study Start
November 9, 2022
Primary Completion
March 8, 2023
Study Completion
March 8, 2023
Last Updated
October 3, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share